BCYC - Bicycle Therapeutics EPS misses by $0.07 misses on revenue November, 07 2019 07:28 AM Bicycle Therapeutics plc Bicycle Therapeutics (NASDAQ:BCYC): Q3 GAAP EPS of -$0.53 misses by $0.07.More news on: Bicycle Therapeutics plc, Earnings news and commentary, Healthcare stocks news, , Read more ...